Evidence map›Paper›PMID 34061620›Full record

ArticlemSystems2021

Precise Species Identification for Acinetobacter: a Genome-Based Study with Description of Two Novel Acinetobacter Species.

Jiayuan Qin, Yu Feng, Xiaoju Lü, Zhiyong Zong

Abstract read
In one paragraph

Article in mSystems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Genomic analysis of carbapenem-resistant non-Frontiers in microbiology · 2026
    Article
  5. Transfer and Fitness of ISMicroorganisms · 2025
    Article
  6. Article
  7. Threat and Control ofFoods (Basel, Switzerland) · 2025
    Review
  8. Exploring the Multifaceted GenusJournal of microbiology and biotechnology · 2025
    Review
  9. Article
  10. Optimizing Treatment for Carbapenem-ResistantInfection & chemotherapy · 2024
    Review
  11. Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiayuan QinCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yu FengCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xiaoju LüCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhiyong ZongCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

National Natural Science Foundation of China (NSFC) 81861138055
6 · The paper itself

Abstract

The genus Acinetobacter comprises species with ecological significance and opportunistic pathogens and has a complicated taxonomy. Precise species identification is a foundation for understanding bacteria. In this study, we found and characterized two novel Acinetobacter species, namely, Acinetobacter tianfuensis sp. nov. and Acinetobacter rongchengensis sp. nov., based on phenotype examinations and genome analyses of the two strains WCHAc060012

Indexed as

Acinetobactergenome analysisphylogenetic analysisquasispeciesspecies

Identifiers

PMID34061620
PMCPMC8269215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.